MAPK3 and familial dilated cardiomyopathy: Furthermore, Studies have shown that hUCMSCs can diminish myocardial fibrosis and EndMT in DCM rats by hindering the activity of TGF-β1/ERK1/2 signaling, suggesting that hUCMSCs could be a potential treatment for DCM [220].